Form 8.3 - Renalytix PLC | 03-May-2024 | 13:34 | RNS |
Form 8.5 (EPT/RI) - Renalytix plc | 03-May-2024 | 12:00 | RNS |
Further update on financing discussions | 03-May-2024 | 08:54 | RNS |
Form 8.5 (EPT/RI) - Renalytix plc | 03-May-2024 | 07:38 | GlobeNewswire NA |
Order received for upgraded hyperpolariser | 03-May-2024 | 07:00 | RNS |
Trading Update | 03-May-2024 | 07:00 | RNS |
Liquidity Agreement and Total Voting Rights | 02-May-2024 | 15:45 | RNS |
IB Announces Expanded Access Program for GaM | 02-May-2024 | 12:47 | RNS |
Form 8.5 (EPT/RI) - Renalytix plc | 02-May-2024 | 12:00 | RNS |
Form 8.3 - Renalytix plc | 02-May-2024 | 07:49 | RNS |
Form 8.5 (EPT/RI) - Renalytix Plc | 02-May-2024 | 07:36 | GlobeNewswire NA |
Transaction in Own Shares | 02-May-2024 | 07:00 | RNS |
Form 8.3 - Renalytix plc | 02-May-2024 | 07:00 | RNS |
Form 8.3 - Renalytix PLC | 02-May-2024 | 07:00 | RNS |
Holding(s) in Company | 01-May-2024 | 17:10 | RNS |
Price | 11,785.09 |
Closing Price Change | 118.80 |
% Change | 1.02 % |
03-May-24 Close | 11,785.09 |
You are here: research